0.55Open0.55Pre Close0 Volume60 Open Interest2.50Strike Price0.00Turnover523.72%IV-16.77%PremiumNov 15, 2024Expiry Date0.83Intrinsic Value100Multiplier9DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.5321Delta0.2904Gamma1.45Leverage Ratio-0.0310Theta-0.0004Rho-0.77Eff Leverage0.0010Vega
Trinity Biotech Stock Discussion
📊⚡️📊
Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform
Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology
Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology
DUBLIN, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the successful completion of its first pre-pivotal clinical trial in Europe for its next-generation continuous glucos...
No comment yet